First congenital heart disease registry launched in Australia
In an Australian first, doctors have developed the Australian New Zealand Congenital Heart Disease Registry to help improve the lives of people living with the condition, and their families.
A pioneering generation: people with complex congenital heart disease living longer
People born with half a heart or single-ventricle congenital heart disease (Fontan-CHD) are now living longer than ever before, thanks to advances in medicine and technology.
Arterial Inflammation and Redox Biology Group publishes in Nature Communications
The Arterial Inflammation and Redox Biology Group, led by Professor Roland Stocker, has published a paper in the prestigious Nature Communications journal.
HRI wins Silver in PRIA Golden Target Awards
A fundraising appeal by the Heart Research Institute (HRI) has won silver in the Golden Target Awards, run by the Public Relations Institute of Australia (PRIA).
Dr Xuyu Liu awarded cardiovascular drug discovery grant
Congratulations to Dr Xuyu Liu on being awarded a Drug Discovery Initiative and Cardiovascular Initiative Partnership Grant for his research “A PROTAC-based bioengineering platform for more efficacious antiplatelet drug discovery”.
Quadruple success for HRI
HRI researchers have been awarded an outstanding four grants under the NSW Cardiovascular Research Capacity Program.
Silent sleep danger for smokers uncovered in world-first study
HRI scientists have discovered people who smoke and also have sleep apnoea - known as the silent killer - are putting themselves in even greater danger of future health complications.
Dr John O’Sullivan awarded 2021 Vanguard Grant
Congratulations to Dr John O’Sullivan on being awarded a Vanguard Grant for his research into “stiff” heart failure.
PhD students are Rising Stars
Congratulations to PhD students Manisha Patil and Ivy Guan, finalists in the NSW CVRN Rising Stars Research competition – the HEART Pitch.